ARCHIVES

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

This article is from The Cancer Letter archive.

Vol. 10 No. 15 | April 13, 1984

Download PDF Visit The Full Archive

Related Articles

Longterm Followup Finds Taxotere Improves Survival

January 25, 2008

Monitoring of Clinical Trials Finds Two Major Problems; Investigators Are Suspended

August 19, 1983

ODAC Unanimously Rejects Melblez, Citing Lower Survival

May 17, 2013

Bioethics Commission Report Calls For funding To Derive Stem Cells

September 17, 1999

Clinical Trials Approved By NCI CTEP Last Month

April 29, 2011

News In Brief: ACS Abandons Plan To Cut Local, Unit Boards Of Directors

October 9, 1998